Blogs

Pharmacy News and Stories

Patient Care

Research    Patient Care    Faculty    Pharmacy

Jeffres Publishes in JAMA Surgery Journal

New research from Dr. Meghan Jeffres, PharmD, Skaggs School of Pharmacy and Pharmaceutical Sciences, Massachusetts General Hospital (MGH), and University of Porto in Portugal, indicates that most surgical patients with a history of penicillin allergy can safely be given the guideline-recommended antibiotic cefazolin to prevent infection instead of alternative antibiotics that are less effective and more expensive. The researchers reported in JAMA Surgery that the frequency of allergies to both penicillins and cefazolin was so small that most patients should receive cefazolin regardless of their allergy history.


Author SOP Communications | Publish Date March 16, 2021
Full Story

School of Pharmacy In the News

Medscape

Time to Test Effects of CBD in Cardiovascular Disease?

news outletMedscape
Publish DateOctober 05, 2022

Robert Page, PharmD, weighs in on the need for well-designed clinical trials to test the safety and efficacy of cannabidiol (CBD) for cardiovascular disease, based on evidence from preclinical studies showing that it has anti-inflammatory effects.

Full Story
Health.com

Cooking Chicken in NyQuil Is a 'Recipe for Danger' FDA Warns, Citing TikTok Video

news outletHealth.com
Publish DateSeptember 22, 2022

Dr. Gina Moore, PharmD, MBA, talks with Health on why this viral TikTok trend is a dangerous misuse of medication.

Full Story
ScienceDaily

Early intervention effective in treating neurodevelopmental disorders

news outletScienceDaily
Publish DateSeptember 07, 2022

A new study from Molly, Huntsman, PhD, suggests that therapeutic interventions to treat neurodevelopmental disorders may be more effective if done during the early stages of brain development.

Full Story
Cancer Health

Lipid Nanoparticles Show Significant Promise in Carrying Cancer Drugs to Tumors

news outletCancer Health
Publish DateSeptember 02, 2022

CU Pharmacy and Cancer Center researcher Dmitri Simberg, PhD, is focusing on penetrating the blood-brain barrier in glioblastoma to more effectively deliver anti-cancer therapies.

Full Story